Acute TNF-induced repression of cell identity genes is mediated by NFκB-directed redistribution of cofactors from super-enhancers

Genome Research

Volumn 25, Issue 9, 2015, Pages 1281-1294

  Schmidt, Søren Fisker ^a   Larsen, Bjørk Ditlev ^a   Loft, Anne ^a   Nielsen, Ronni ^a   Madsen, Jesper Grud Skat ^a,b   Mandrup, Susanne ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b Capital Region   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BROMODOMAIN CONTAINING PROTEIN 4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING PROTEIN; PROTEIN; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; BRD4 PROTEIN, HUMAN; NUCLEAR PROTEIN; PROTEIN BINDING; TRANSCRIPTION FACTOR; TRANSCRIPTOME;

ADIPOCYTE; ADIPOGENESIS; ARTICLE; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CHROMATIN STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; ENHANCER REGION; GENE ACTIVATION; GENE CONTROL; GENE IDENTIFICATION; GENE INDUCTION; GENE REPRESSION; HUMAN; HUMAN CELL; INTRON; LIPID METABOLISM; PRIORITY JOURNAL; ANTIBODY SPECIFICITY; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NUCLEAR REPROGRAMMING; PROTEIN TRANSPORT;

ADIPOCYTES; CELL DIFFERENTIATION; CELLULAR REPROGRAMMING; ENHANCER ELEMENTS, GENETIC; GENE EXPRESSION REGULATION; HUMANS; MEDIATOR COMPLEX SUBUNIT 1; NF-KAPPA B; NUCLEAR PROTEINS; ORGAN SPECIFICITY; PROTEIN BINDING; PROTEIN TRANSPORT; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTORS; TRANSCRIPTOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84941000331     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.188300.114     Document Type: Article

References (65)

1. Agalioti T, Lomvardas S, Parekh B, Yie J, Maniatis T, Thanos D. 2000. Ordered recruitment of chromatin modifying and general transcription factors to the IFN-β promoter. Cell 103: 667-678.
2. Barboric M, Nissen RM, Kanazawa S, Jabrane-Ferrat N, Peterlin BM. 2001. NF-κB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II. Mol Cell 8: 327-337.
3. Baumgartner BL, Bennett MR, Ferry M, Johnson TL, Tsimring LS, Hasty J. 2011. Antagonistic gene transcripts regulate adaptation to new growth environments. Proc Natl Acad Sci 108: 21087-21092.
4. Boergesen M, Poulsen LC, Schmidt SF, Frigerio F, Maechler P, Mandrup S. 2011. ChREBP mediates glucose repression of peroxisome proliferatoractivated receptor α expression in pancreatic β-cells. J Biol Chem 286: 13214-13225.
5. Bonn S, Zinzen RP, Girardot C, Gustafson EH, Perez-Gonzalez A, Delhomme N, Ghavi-Helm Y, Wilczynski B, Riddell A, Furlong EE. 2012. Tissue-specific analysis of chromatin state identifies temporal signatures of enhancer activity during embryonic development. Nat Genet 44: 148-156.
6. Brown JD, Lin CY, Duan Q, Griffin G, Federation AJ, Paranal RM, Bair S, Newton G, Lichtman AH, Kung AL, et al. 2014. NF-κB directs dynamic super enhancer formation in inflammation and atherogenesis. Mol Cell 56: 219-231.
7. Cawthorn WP, Sethi JK. 2008. TNF-α and adipocyte biology. FEBS Lett 582: 117-131.
8. Crawford GE, Holt IE, Whittle J, Webb BD, Tai D, Davis S, Margulies EH, Chen Y, Bernat JA, Ginsburg D, et al. 2006. Genome-wide mapping of DNase hypersensitive sites using massively parallel signature sequencing (MPSS). Genome Res 16: 123-131.
9. Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR. 2013. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29: 15-21.
10. Filippakopoulos P, Qi J, Picaud S, Shen Y, Smith WB, Fedorov O, Morse EM, Keates T, Hickman TT, Felletar I, et al. 2010. Selective inhibition of BET bromodomains. Nature 468: 1067-1073.
11. Gao Z, Chiao P, Zhang X, Lazar MA, Seto E, Young HA, Ye J. 2005. Coactivators and corepressors of NF-κB in IκB α gene promoter. J Biol Chem 280: 21091-21098.
12. Grosveld F, van-Assendelft GB, Greaves DR, Kollias G. 1987. Position-independent, high-level expression of the human β-globin gene in transgenic mice. Cell 51: 975-985.
13. Guertin MJ, Zhang X, Coonrod SA, Hager GL. 2014. Transient estrogen receptor binding and p300 redistribution support a squelching mechanism for estradiol-repressed genes. Mol Endocrinol 28: 1522-1533.
14. Guilherme A, Virbasius JV, Puri V, Czech MP. 2008. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 9: 367-377.
15. Hah N, Benner C, Chong LW, Yu RT, Downes M, Evans RM. 2015. Inflammation-sensitive super enhancers form domains of coordinately regulated enhancer RNAs. Proc Natl Acad Sci 112: E297-E302.
16. He HH, Meyer CA, Chen MW, Jordan VC, Brown M, Liu XS. 2012. Differential DNase I hypersensitivity reveals factor-dependent chromatin dynamics. Genome Res 22: 1015-1025.
17. Heintzman ND, Hon GC, Hawkins RD, Kheradpour P, Stark A, Harp LF, Ye Z, Lee LK, Stuart RK, Ching CW, et al. 2009. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 459: 108-112.
18. Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, Cheng JX, Murre C, Singh H, Glass CK. 2010. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 38: 576-589.
19. Hnisz D, Abraham BJ, Lee TI, Lau A, Saint-Andre V, Sigova AA, Hoke HA, Young RA. 2013. Super-enhancers in the control of cell identity and disease. Cell 155: 934-947.
20. Huang B, Yang XD, Zhou MM, Ozato K, Chen LF. 2009. Brd4 coactivates transcriptional activation of NF-κB via specific binding to acetylated RelA. Mol Cell Biol 29: 1375-1387.
21. Jin F, Li Y, Ren B, Natarajan R. 2011. PU.1 and C/EBPα synergistically program distinct response to NF-κB activation through establishing monocyte specific enhancers. Proc Natl Acad Sci 108: 5290-5295.
22. Jin F, Li Y, Dixon JR, Selvaraj S, Ye Z, Lee AY, Yen CA, Schmitt AD, Espinoza CA, Ren B. 2013. A high-resolution map of the three-dimensional chromatin interactome in human cells. Nature 503: 290-294.
23. Jonat C, Rahmsdorf HJ, Park KK, Cato AC, Gebel S, Ponta H, Herrlich P. 1990. Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62: 1189-1204.
24. Kagey MH, Newman JJ, Bilodeau S, Zhan Y, Orlando DA, van Berkum NL, Ebmeier CC, Goossens J, Rahl PB, Levine SS, et al. 2010. Mediator and cohesin connect gene expression and chromatin architecture. Nature 467: 430-435.
25. Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin SC, Heyman RA, Rose DW, Glass CK, et al. 1996. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85: 403-414.
26. Karin M, Ben-Neriah Y. 2000. Phosphorylation meets ubiquitination: The control of NF-κB activity. Annu Rev Immunol 18: 621-663.
27. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D. 2002. The human genome browser at UCSC. Genome Res 12: 996-1006.
28. Kim T, Hemberg M, Gray J, Costa A, Bear D, Wu J, Harmin D, Laptewicz M, Barbara-Haley K, Kuersten S, et al. 2010. Widespread transcription at neuronal activity-regulated enhancers. Nature 465: 182-187.
29. Lackner DH, Schmidt MW, Wu S, Wolf DA, Bahler J. 2012. Regulation of transcriptome, translation, and proteome in response to environmental stress in fission yeast. Genome Biol 13: R25.
30. Lee MV, Topper SE, Hubler SL, Hose J, Wenger CD, Coon JJ, Gasch AP. 2011. A dynamic model of proteome changes reveals new roles for transcript alteration in yeast. Mol Syst Biol 7: 514.
31. Lo KA, Labadorf A, Kennedy NJ, Han MS, Yap YS, Matthews B, Xin X, Sun L, Davis RJ, Lodish HF, et al. 2013. Analysis of in vitro insulin-resistance models and their physiological relevance to in vivo diet-induced adipose insulin resistance. Cell Rep 5: 259-270.
32. Loft A, Forss I, Siersbæk MS, Schmidt SF, Larsen AS, Madsen JG, Pisani DF, Nielsen R, Aagaard MM, Mathison A, et al. 2015. Browning of human adipocytes requires KLF11 and reprogramming of PPARγ superenhancers. Genes Dev 29: 7-22.
33. Loven J, Hoke HA, Lin CY, Lau A, Orlando DA, Vakoc CR, Bradner JE, Lee TI, Young RA. 2013. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 153: 320-334.
34. Madsen JG, Schmidt SF, Larsen BD, Loft A, Nielsen R, Mandrup S. 2015. iRNA-seq: computational method for genome-wide assessment of acute transcriptional regulation from total RNA-seq data. Nucleic Acids Res 43: E40.
35. Maury E, Brichard SM. 2010. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol 314: 1-16.
36. Meyer ME, Gronemeyer H, Turcotte B, Bocquel MT, Tasset D, Chambon P. 1989. Steroid hormone receptors compete for factors that mediate their enhancer function. Cell 57: 433-442.
37. Moynagh PN. 2005. The NF-κB pathway. J Cell Sci 118: 4589-4592.
38. Natoli G. 2009. Control of NF-κB-dependent transcriptional responses by chromatin organization. Cold Spring Harb Perspect Biol 1: A000224.
39. Nielsen R, Mandrup S. 2014. Genome-wide profiling of transcription factor binding and epigenetic marks in adipocytes by ChIP-seq. Methods Enzymol 537: 261-279.
40. Nielsen R, Pedersen TA, Hagenbeek D, Moulos P, Siersbæk R, Megens E, Denissov S, Børgesen M, Francoijs KJ, Mandrup S, et al. 2008. Genome-wide profiling of PPARγ:RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis. Genes Dev 22: 2953-2967.
41. Parker SC, Stitzel ML, Taylor DL, Orozco JM, Erdos MR, Akiyama JA, van-Bueren KL, Chines PS, Narisu N, Black BL, et al. 2013. Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants. Proc Natl Acad Sci 110: 17921-17926.
42. Pascual G, Fong AL, Ogawa S, Gamliel A, Li AC, Perissi V, Rose DW, Willson TM, Rosenfeld MG, Glass CK. 2005. A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ. Nature 437: 759-763.
43. Quinlan AR. 2014. BEDTools: The Swiss-Army tool for genome feature analysis. Curr Protoc Bioinformatics 47: 11.12.1-11.12.34.
44. Raich N, Enver T, Nakamoto B, Josephson B, Papayannopoulou T, Stamatoyannopoulos G. 1990. Autonomous developmental control of human embryonic globin gene switching in transgenic mice. Science 250: 1147-1149.
45. Rao NA, McCalman MT, Moulos P, Francoijs KJ, Chatziioannou A, Kolisis FN, Alexis MN, Mitsiou DJ, Stunnenberg HG. 2011. Coactivation of GR and NFKB alters the repertoire of their binding sites and target genes. Genome Res 21: 1404-1416.
46. Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, Muller M. 2011. pROC: An open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 12: 77.
47. Robinson MD, McCarthy DJ, Smyth GK. 2010. edgeR: A Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26: 139-140.
48. Ruan H, Hacohen N, Golub TR, Van Parijs L, Lodish HF. 2002. Tumor necrosis factor-α suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-κB activation by TNF-α is obligatory. Diabetes 51: 1319-1336.
49. Ryden M, Dicker A, van-Harmelen V, Hauner H, Brunnberg M, Perbeck L, Lonnqvist F, Arner P. 2002. Mapping of early signaling events in tumor necrosis factor-α-mediated lipolysis in human fat cells. J Biol Chem 277: 1085-1091.
50. Schmidt SF, Jørgensen M, Chen Y, Nielsen R, Sandelin A, Mandrup S. 2011. Cross species comparison of C/EBPα and PPARγ profiles in mouse andhuman adipocytes reveals interdependent retention of binding sites. BMC Genomics 12: 152.
51. Siersbæk R, Nielsen R, John S, Sung MH, Baek S, Loft A, Hager GL, Mandrup S. 2011. Extensive chromatin remodelling and establishment of transcription factor 'hotspots' during early adipogenesis. EMBO J 30: 1459-1472.
52. Siersbæk MS, Loft A, Aagaard MM, Nielsen R, Schmidt SF, Petrovic N, Nedergaard J, Mandrup S. 2012. Genome-wide profiling of peroxisome proliferator-activated receptor γ in primary epididymal, inguinal, and brown adipocytes reveals depot-selective binding correlated with gene expression. Mol Cell Biol 32: 3452-3463.
53. Siersbæk R, Rabiee A, Nielsen R, Sidoli S, Traynor S, Loft A, La Cour Poulsen L, Rogowska-Wrzesinska A, Jensen ON, Mandrup S. 2014. Transcription factor cooperativity in early adipogenic hotspots and super-enhancers. Cell Rep 7: 1443-1455.
54. Step SE, Lim HW, Marinis JM, Prokesch A, Steger DJ, You SH, Won KJ, Lazar MA. 2014. Anti-diabetic rosiglitazone remodels the adipocyte transcriptome by redistributing transcription to PPARγ-driven enhancers. Genes Dev 28: 1018-1028.
55. Tang X, Guilherme A, Chakladar A, Powelka AM, Konda S, Virbasius JV, Nicoloro SM, Straubhaar J, Czech MP. 2006. An RNA interference-based screen identifies MAP4K4/NIK as a negative regulator of PPARγ, adipogenesis, and insulin-responsive hexose transport. Proc Natl Acad Sci 103: 2087-2092.
56. Tang Q, Chen Y, Meyer C, Geistlinger T, Lupien M, Wang Q, Liu T, Zhang Y, Brown M, Liu XS. 2011. A comprehensive view of nuclear receptor cancer cistromes. Cancer Res 71: 6940-6947.
57. Turer AT, Scherer PE. 2012. Adiponectin: mechanistic insights and clinical implications. Diabetologia 55: 2319-2326.
58. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. 1997. Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature 389: 610-614.
59. Ventre J, Doebber T, Wu M, MacNaul K, Stevens K, Pasparakis M, Kollias G, Moller DE. 1997. Targeted disruption of the tumor necrosis factor-α gene: metabolic consequences in obese and nonobese mice. Diabetes 46: 1526-1531.
60. Whyte WA, Orlando DA, Hnisz D, Abraham BJ, Lin CY, Kagey MH, Rahl PB, Lee TI, Young RA. 2013. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 153: 307-319.
61. Yang J, Mitra A, Dojer N, Fu S, Rowicka M, Brasier AR. 2013. A probabilistic approach to learn chromatin architecture and accurate inference of the NF-κB/RelA regulatory network using ChIP-Seq. Nucleic Acids Res 41: 7240-7259.
62. Ye J. 2008. Regulation of PPARγ function by TNF-α. Biochem Biophys Res Commun 374: 405-408.
63. Zhang B, Berger J, Hu E, Szalkowski D, White-Carrington S, Spiegelman BM, Moller DE. 1996. Negative regulation of peroxisome proliferator-activated receptor-γ gene expression contributes to the antiadipogenic effects of tumor necrosis factor-α. Mol Endocrinol 10: 1457-1466.
64. Zhang HH, Halbleib M, Ahmad F, Manganiello VC, Greenberg AS. 2002. Tumor necrosis factor-α stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP. Diabetes 51: 2929-2935.
65. Zhao W, Breese E, Bowers A, Hoggatt J, Pelus LM, Broxmeyer HE, Goebl M, Harrington MA. 2013. SIMPL enhancement of tumor necrosis factor-α dependent p65-MED1 complex formation is required for mammalian hematopoietic stem and progenitor cell function. PLoS One 8: E61123.